Jacques Bogart SA (JBOG)
Euronext Paris · France · prices in EUR · close of 19 Oct 2026
Key indicators
| Last close | EUR 1.705 |
|---|---|
| 52-week range | 1.620 – 4.600 |
| Return, 1 month / 3 months | −9.5% / −27.4% |
| Return, 1 year / 3 years | −54.4% / −75.1% |
| Trend | Below its 200-day average |
| RSI (14) | 32 |
| Volatility (1 year) | 56.4% |
| Worst drawdown (1 year) | -62.8% |
| Average daily value traded | 0.00M EUR |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Jacques Bogart is a French fragrance and cosmetics company based near Paris. It creates and markets perfumes and beauty products under its own brands, including Jacques Bogart, Carven, Ted Lapidus and Chevignon, and distributes them through pharmacies, perfumeries and other retailers. The group also runs its own chain of beauty stores in France, offering cosmetics, toiletries and related products to everyday shoppers. Its business spans both the creation of branded scents and the retail of beauty goods.
On this site Jacques Bogart SA appears as a stock on the Euronext Paris (France), code JBOG, with prices in euros (EUR). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Jacques Bogart SA (JBOG) trades on the Euronext Paris in France. It last closed at EUR 1.705 on 19 October 2026.
Its price-based Market X-Ray is 17 out of 100 (a weak price profile), ranking 588 of 625 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 54.4% and over the last three months it fell 27.4%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Euronext Paris
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 11 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -35.4% | ||
| From 52-week high | -62.8% | ||
| Momentum | 11 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -27.4% | ||
| 6-month return | -45.9% | ||
| 12-month return, skipping the last month | -49.6% | ||
| Stability (higher is calmer) | 25 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 56.4% | ||
| Worst drawdown, 1 year (smaller is calmer) | -62.8% | ||
| Liquidity | 24 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.00M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 4 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | −12.6% |
|---|---|
| 1 month | −9.5% |
| 3 months | −27.4% |
| 6 months | −45.9% |
| 1 year | −54.4% |
| 3 years | −75.1% |
| 5 years | – |
Signals
| 50-day / 200-day average | 1.995 / 2.640 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.083 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 2 Jul 2025 | EUR 0.1600 |
| 3 Jul 2024 | EUR 0.2000 |
| 5 Jul 2023 | EUR 0.1800 |
| 5 Jul 2022 | EUR 0.2300 |
| 2 Jul 2021 | EUR 0.2300 |
| 23 Jul 2020 | EUR 0.2300 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Euronext Paris; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.